Н. А. Абрамова
Ministry of Health of the Russian Federation · 24 works · 28 citations · h-index 3
Top works
- HORMONE-POSITIVE HER2-NEGATIVE METASTATIC BREAST CANCER: DECISION MAKING IN REAL CLINICAL PRACTICE
- Epoetin alpha in the treatment of anemia in patients with malignant solid tumors during antitumor drug therapy
- Dynamics of changes in expression of VEGF neoangiogenic factor in tumor tissue bioptates in patients with squamous cell carcinoma of oral mucosa receiving cetuximab treatment and chemotherapy
- Some aspects of nivolumab administration in treatment for metastatic melanoma (clinical cases)
- MORPHOFUNCTIONAL CHARACTERISTICS OF HEMATOPOIETIC TISSUE IN LYMPHOMA PATIENTS
- Metastasectomy in patients with non-resectable metastatic colorectal cancer receiving chemotherapy and anti-EGFR antibodies: a prospective, non-randomized, multicenter, phase II study
- A study of prevalence of polymorphic variants of genes of blood coagulation factors in onco-logical patients
- Modern aspects of immunotherapy with checkpoint inhibitors in melanoma
- Dynamics of changes in type 1 and 2 insulinlike growth factors in the blood of patients with oral squamous cell cancer after targeted therapy with cetuximab
- A case of long-term use of denosumab for giant cell tumor of bone
- Study of EGFR expression in tumor tissue in patients with locally advanced oral cavity cancer receiving cetuximab therapy
- Опыт применения препарата тимодепрессин при проведении химиотерапии больным раком молочной железы
- Опыт применения препарата резорба в лечении больных раком молочной железы с метастазами в кости
- Trastuzumab emtansine of the treatment of HER2-positive breast cancer with brain metatases
- A60
- Ftorafur - pervyy peroral'nyy ftorpirimidin v terapii metastaticheskogo kolorektal'nogo raka
- P-144 Anti –EGRF Monoclonal Antibodies and Surgery of Metastases in the Treatments of Metastatic Colorectal Cancer (mCRC)
- Anti-PD‑1-induced type 1 diabetes mellitus in patient with recurrent oropharyngeal squamous cell cancer
- Identifying prognostic subgroups for outcomes in wild-type RAS metastatic colorectal cancer (mCRC) treated with anti-EGFR drugs
- Таргетная терапия анти –EGFR моноклональными антителами в лечении колоректального рака